CYREN
Basic information
Region (hg38): 7:135092363-135170795
Previous symbols: [ "C7orf49" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYREN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 2 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 1 | 1 | 1 |
Variants in CYREN
This is a list of pathogenic ClinVar variants found in the CYREN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-135115454-A-G | not specified | Uncertain significance (Nov 25, 2024) | ||
7-135115461-A-C | not specified | Uncertain significance (May 13, 2022) | ||
7-135134832-C-A | Benign (Jun 11, 2018) | |||
7-135134849-C-T | Likely benign (Dec 31, 2019) | |||
7-135134864-A-C | not specified | Uncertain significance (May 24, 2024) | ||
7-135134894-C-T | not specified | Uncertain significance (Jan 23, 2023) | ||
7-135134918-T-A | not specified | Uncertain significance (Jun 13, 2022) | ||
7-135134933-T-G | not specified | Uncertain significance (Jan 10, 2023) | ||
7-135134950-T-C | not specified | Uncertain significance (Sep 20, 2024) | ||
7-135134965-C-T | not specified | Likely benign (Apr 08, 2022) | ||
7-135135071-A-G | not specified | Uncertain significance (Apr 15, 2024) | ||
7-135135098-G-C | not specified | Uncertain significance (Mar 02, 2023) | ||
7-135135190-A-C | not specified | Uncertain significance (Jan 24, 2023) | ||
7-135135193-A-G | not specified | Uncertain significance (May 30, 2024) | ||
7-135135197-A-G | not specified | Uncertain significance (Sep 03, 2024) | ||
7-135135199-G-A | not specified | Uncertain significance (Sep 27, 2021) | ||
7-135135209-A-G | not specified | Uncertain significance (Aug 20, 2024) | ||
7-135164448-G-A | not specified | Likely benign (Jan 25, 2024) | ||
7-135164502-G-C | not specified | Uncertain significance (Jun 16, 2024) | ||
7-135164551-G-T | not specified | Uncertain significance (Oct 04, 2024) | ||
7-135164564-C-A | not specified | Uncertain significance (Feb 05, 2024) | ||
7-135164583-G-A | not specified | Uncertain significance (Dec 13, 2023) | ||
7-135164611-A-G | not specified | Uncertain significance (Dec 28, 2022) | ||
7-135164706-G-A | not specified | Uncertain significance (Jan 19, 2022) | ||
7-135164709-T-C | not specified | Uncertain significance (Feb 23, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYREN | protein_coding | protein_coding | ENST00000393114 | 3 | 78433 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.260 | 0.647 | 125736 | 0 | 6 | 125742 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.294 | 85 | 93.0 | 0.914 | 0.00000511 | 1023 |
Missense in Polyphen | 23 | 25.042 | 0.91847 | 295 | ||
Synonymous | -0.564 | 44 | 39.5 | 1.11 | 0.00000252 | 320 |
Loss of Function | 1.24 | 1 | 3.52 | 0.284 | 1.49e-7 | 42 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000907 | 0.0000904 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Isoform 1: Cell-cycle-specific inhibitor of classical non-homologous end joining (NHEJ) of DNA double-strand break (DSB) repair during the S and G2 phases (PubMed:28959974). Acts as a regulator of DNA repair pathway choice by specifically inhibiting classical NHEJ during the S and G2 phases, thereby promoting error-free repair by homologous recombination during cell cycle phases when sister chromatids are present (PubMed:28959974). Preferentially protects single-stranded overhangs at break sites by inhibiting classical NHEJ, thereby creating a local environment that favors homologous recombination (PubMed:28959974). Acts via interaction with XRCC5/Ku80 and XRCC6/Ku70, interaction restricted during the S and G2 phases only (PubMed:28959974). Molecular mechanisms governing classical NHEJ inhibition via interaction with XRCC5/Ku80 and XRCC6/Ku70 are unknown (PubMed:28959974). May act as a regulator of proteasome (By similarity). {ECO:0000250|UniProtKB:Q09HN1, ECO:0000269|PubMed:28959974}.;
Intolerance Scores
- loftool
- rvis_EVS
- -0.01
- rvis_percentile_EVS
- 53.19
Haploinsufficiency Scores
- pHI
- 0.0530
- hipred
- N
- hipred_score
- 0.146
- ghis
- 0.457
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Cyren
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- double-strand break repair via nonhomologous end joining;negative regulation of double-strand break repair via nonhomologous end joining
- Cellular component
- nucleus;cytoplasm
- Molecular function
- protein binding